Plasma levels of asymmetrical dimethyl-L-arginine in patients with congenital heart disease and pulmonary hypertension

Journal of Cardiovascular Pharmacology

Volumn 37, Issue 4, 2001, Pages 489-492

  Gorenflo, M ^a   Zheng, C ^a   Werle, E ^a   Fiehn, W ^a   Ulmer, H E ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Congenital heart disease; Nitric oxide synthase; Pulmonary hypertension

Indexed keywords

ARGININE DERIVATIVE; NITRIC OXIDE SYNTHASE INHIBITOR;

ADOLESCENT; ADULT; ARTICLE; BLOOD LEVEL; CHILD; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; ENZYME INHIBITION; HEART CATHETERIZATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LUNG PERFUSION; LUNG RESISTANCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; VENOUS BLOOD;

ADOLESCENT; ADULT; ARGININE; CHILD; CHILD, PRESCHOOL; ENZYME INHIBITORS; HEART DEFECTS, CONGENITAL; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION, PULMONARY; INFANT; NITRIC OXIDE SYNTHASE;

EID: 0035085477     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200104000-00016     Document Type: Article

References (10)

1. Regulation of pulmonary vascular tone
2. Impairment of endothelium-dependent pulmonary artery relaxation in children with congenital heart disease and abnormal pulmonary hemodynamics
3. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure
4. Biological significance of endogenous methylarginines that inhibit nitric oxide synthases
5. Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease
6. Lung biopsy in congenital heart disease: A morphometric approach to pulmonary vascular disease
7. Cardiac catheterization: Hemodynamic measurements
8. The estimation of oxygen consumption
9. Primary pulmonary hypertension. A national prospective study
10. Elevation of an endogenous inhibitor of nitric oxide synthesis in experimental congestive heart failure